Welcome to LookChem.com Sign In|Join Free

CAS

  • or

944401-56-3

2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE is a pyridine derivative chemical compound with the formula C6H4BrF3N2. It features a bromine substituent at the 5-position and a trifluoromethyl group at the 4-position, which contributes to its high reactivity and versatility in synthetic chemistry.

944401-56-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 944401-56-3 Structure

  • Basic information

    1. Product Name: 2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE
    2. Synonyms: 2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE;5-bromo-4-(trifluoromethyl)-2-pyridylamine;5-BroMo-4-trifluoroMethyl-pyridin-2-ylaMine;2-Pyridinamine, 5-bromo-4-(trifluoromethyl)-
    3. CAS NO:944401-56-3
    4. Molecular Formula: C6H4BrF3N2
    5. Molecular Weight: 241.0085696
    6. EINECS: -0
    7. Product Categories: N/A
    8. Mol File: 944401-56-3.mol

  • Chemical Properties

    1. Melting Point: 71-74℃
    2. Boiling Point: 243.9 °C at 760 mmHg
    3. Flash Point: 101.3 °C
    4. Appearance: Pale yellow to orange/Solid
    5. Density: 1.79 g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
    8. Solubility: soluble in Methanol
    9. PKA: 2.44±0.24(Predicted)
    10. CAS DataBase Reference: 2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE(944401-56-3)
    12. EPA Substance Registry System: 2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE(944401-56-3)

  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 20/21/22-36/37/38-36-22
    3. Safety Statements: 22-24/25-26-36/37/39
    4. WGK Germany: 1
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 944401-56-3(Hazardous Substances Data)

944401-56-3 Usage

Uses

Used in Pharmaceutical Industry:
2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE is used as a building block for the synthesis of various biologically active pharmaceutical drugs. Its unique structure allows for the creation of molecules with specific therapeutic properties, making it a valuable component in drug discovery and development.
Used in Agrochemical Industry:
In the agrochemical sector, 2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE serves as a key intermediate in the production of crop protection chemicals. Its incorporation into these chemicals enhances their effectiveness in protecting crops from pests and diseases, thereby contributing to increased agricultural productivity.
Used as a Reagent in Organic Synthesis:
2-AMINO-5-BROMO-4-TRIFLUOROMETHYLPYRIDINE is utilized as a reagent to introduce amino and bromo functional groups into organic molecules. Its high reactivity and ability to participate in a wide range of chemical reactions make it an indispensable tool for chemists in various organic synthesis processes.

Check Digit Verification of cas no

The CAS Registry Mumber 944401-56-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,4,0 and 1 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 944401-56:
(8*9)+(7*4)+(6*4)+(5*4)+(4*0)+(3*1)+(2*5)+(1*6)=163
163 % 10 = 3
So 944401-56-3 is a valid CAS Registry Number.
InChI:InChI:1S/C6H10BrF3N2/c7-4-2-12-5(11)1-3(4)6(8,9)10/h3-5,12H,1-2,11H2

944401-56-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail

  • Alfa Aesar

  • (H64936)  2-Amino-5-bromo-4-(trifluoromethyl)pyridine, 95%   

  • 944401-56-3

  • 250mg

  • 542.0CNY

  • Detail

  • Alfa Aesar

  • (H64936)  2-Amino-5-bromo-4-(trifluoromethyl)pyridine, 95%   

  • 944401-56-3

  • 1g

  • 1813.0CNY

  • Detail

  • Aldrich

  • (730483)  2-Amino-5-bromo-4-(trifluoromethyl)pyridine  95%

  • 944401-56-3

  • 730483-500MG

  • 1,421.55CNY

  • Detail

944401-56-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromo-4-(trifluoromethyl)pyridin-2-amine

1.2 Other means of identification

Product number -
Other names 5-bromo-4-(trifluoromethyl)pyridin-2-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:944401-56-3 SDS

944401-56-3Relevant articles and documents

Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives

Chen, Yan-Hong,Ding, Jian,Meng, Ling-Hua,Wang, Yi,Xiang, Hao-Yue,Yang, Chun-Hao,Zhang, Xi

, (2020)

A series of 6-aminocarbonyl pyrrolo[2,1-f][1,2,4]triazine derivatives were designed by scaffold hopping strategy. The IC50 values of compound 14a against PI3Ks were measured, showing selective activity against p110α and p110δ with IC50s of 122 nM and 119 nM respectively. All the synthesized compounds were evaluated for their antiproliferative activity against human cancer cells by SRB assay. Compounds 14a, 14p and 14q exhibited potent antiproliferative activity against five types of human cancer cells and the PK property of 14q was also investigated here.

Preparation method and use of deuterated triazine compounds

-

Paragraph 0040-0043, (2019/10/01)

The present invention discloses a preparation method and a use of deuterated triazine compounds represented by formula (I), or pharmaceutically acceptable salts thereof. The deuterated triazine compounds of the present invention can be used for a PI3K/mTOR inhibitor.

Oxadiazolopyridine Derivates for Use as Ghrelin O-Acyl Transferase (GOAT) Inhibitors

-

Paragraph 0302-0306; 0381-0383, (2018/03/01)

The present invention relates to compounds of general formula I, wherein the groups R1, R2 and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.

MECHANISTIC TARGET OF RAPAMYCIN SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF

-

Paragraph 00209; 00210, (2018/04/11)

Selective mTOR inhibitors of formulas (I)-(III), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from abnormal cell growth, functions, or behaviors mediated by an mTOR kinase and/or one or more PI3K enzyme, are provided. Such diseases and disorder include cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine function disorders and neurological disorders.

4-(AZETIDIN-1-YL)PYRIMIDINE DERIVATIVES WITH ANTI-MITOTIC AND ANTI-PROLIFERATIVE ACTIVITY

-

Paragraph 0161; 0162, (2017/11/04)

The invention relates to 4-(azetidin-1-yl)pyrimidyl compounds of formula (I), wherein X and Y are, independently of each other CH or N; U is O, CHOH, CHCH2OH, C(CH3)OH, CO, CHNH2; R1 and R2 are, independently of each other H, F or CH3; and R3 is H or CH3; and related compounds with anti-mitotic and anti-proliferative properties, and methods of making use of such compounds in therapy or diagnostics to attenuate undesired cell proliferation, growth, migration, metastasis tumor formation, and inflammatory conditions. Additionally, methods are disclosed of treating diseases associated with undesired angiogenesis and undesired proliferation, and methods of treating infectious and inflammatory diseases using such compounds.

2-MORPHOLIN-4,6-DISUBSTITUTED PYRIMIDINE DERIVATIVE, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF

-

Paragraph 0091-0092, (2017/11/11)

Disclosed is a 2-morpholin-4,6-disubstituted pyrimidine derivative as shown in formula (I) below, and a pharmaceutically acceptable salt, solvate, stereoisomer or prodrug thereof, and a pharmaceutical composition thereof and a use thereof, wherein the definition of each group is as shown in the description. The compound has a PI3K kinase inhibition activity, and has a relatively high inhibitive ability and a low cytotoxicity against PIK3CA mutant breast cancer cell strains T47D and MCF-7.

And circular PI3K inhibitors (by machine translation)

-

Paragraph 0367; 0368; 0369, (2016/10/08)

The invention belongs to the field of medical technology, in particular to general formula (I) and of the everted shown in the PI3K inhibitor, or a pharmaceutically acceptable salt, ester, stereo isomers, solvates, wherein R 1, R 2, R 3 as defined in the specification. The invention also relates to methods of preparing such compounds, pharmaceutical formulations containing these compounds and pharmaceutical compositions, use of these compounds in the preparation and treatment and/or prevention of proliferative diseases of application of the medicament. (by machine translation)

PI3K kinase inhibitor, to pharmaceutical compositions comprising the same and application thereof

-

Paragraph 0131-0134, (2016/11/24)

The invention discloses a phosphoinositide 3-kinase (P13K) inhibitor, a pharmaceutical composition containing the P13K inhibitor, and application of the P13K inhibitor and the pharmaceutical composition. The P13K inhibitor comprises a pyrimidine compound and a stereoisomer/hydrate/pharmaceutically-acceptable salt thereof. The pyrimidine compound has a general formula I of which the structure is shown in the specification. The P13K inhibitor and the pharmaceutical composition containing the same can be used for inhibiting PI3 Ks and treating proliferative diseases on which the PI3 Ks act. According to the invention, high-effectiveness and high-selectivity inhibitors for treating proliferative diseases on which PI3Ks act can be provided.

Pyrimidine compounds, PI3K inhibitors, include PI3K inhibitor drug composition and use thereof

-

Paragraph 0093-0096, (2017/01/31)

The invention discloses a pyrimidine compound of which the structure is shown in a general formula (I), and also discloses a PI3K inhibitor which is composed of at least one of the following substances: the pyrimidine compound shown in the general formula

Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents

Peng, Wei,Tu, Zheng-Chao,Long, Zi-Jie,Liu, Quentin,Lu, Gui

, p. 644 - 654 (2015/12/31)

In this study, a series of novel 7 or 8-substituted 4-morpholine-quinazoline derivatives was designed and synthesized. Their PI3Kα inhibitory activities, antiproliferative activities against seven cancer cell lines, namely, PC-3, DU145, MCF-7, BT474, SK-BR-3, U937 and A431, were evaluated in vitro. Compound 17f proved to be a potential drug candidate with high PI3Kα inhibition activity (IC50 = 4.2 nM) and good antiproliferative activity. Compound 17f was also tested for its inhibitory activities against other kinases, such as PI3Kβ, PI3Kγ, PI3Kδ and mTOR, its effects on p-Akt (S473) and cell cycle. These results suggested that compound 17f could significantly inhibit the PI3K/Akt/mTOR pathway as a potent PI3K inhibitor and anticancer agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 944401-56-3